Press release
Infectious Disease Molecular Diagnostics Tests Market: Trends and Forecast 2015 - 2023
In terms of regional distribution, North America followed by Europe account for the largest market share of infectious disease molecular diagnostics tests market due to the market availability of the tests and high incidence rate of various infectious disease such as HPV, hepatitis and bacterial infections. According to an article published in the World Journal of Hepatology, each year around 1.5 million clinical cases of hepatitis A occur globally.
Obtain Report Details @ http://www.transparencymarketresearch.com/infectious-disease-testing-instrumentation.html
In addition, other regions such as Asia Pacific, Latin America as well as Middle East, are expected to be the potential markets in the near future. Due to the high adoption rate of advanced molecular diagnostic tests and exponentially growing healthcare industry, these regions are expected to be the potential market in the near future.
Across the globe, the overall infectious disease molecular diagnostics tests market is witnessing a considerable pressure and rapid development. Moreover, increasing incidence rate of infectious diseases such as respiratory diseases, bacterial infections, HIV and HPV are expected to boost the market growth of the infectious disease molecular diagnostic tests market in the near future. For instance, according to the UNAIDS (The Joint United Nations Programme on HIV/AIDS), in 2012, approximately 1.3 million people were living with HIV, in the U.S.
Furthermore, the WHO claims that, at the end of 2013, globally, approximately, 35 million individuals were living with HIV. Thus, this large base of HIV patients is expected to drive the market growth of infectious disease molecular diagnostic tests market across the globe. Furthermore, advantages of molecular diagnostic tests such as ability to identify multiple strains of respiratory viruses and ability to monitor the level of HIV virus in the person’s blood for determining the type of treatment would contribute to the growth of this market. However, high cost of these tests and availability of the tests kits are some of the factors that might negatively influence the growth of this market.
Enter your information below to receive a sample copy of this report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3852
Currently, the global infectious disease molecular diagnostics tests market is highly fragmented and competitive owing to the presence of many global as well as emerging players in the infectious molecular diagnostic tests market. The market is expected to witness a significantly high growth rate due to the increasing incidence of infectious diseases and introduction of advanced diagnostic technologies in the field healthcare industry. Major companies operating in the field of infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Molecular Diagnostics Tests Market: Trends and Forecast 2015 - 2023 here
News-ID: 570591 • Views: …
More Releases from Transparency Market Research
Europe Insect Screen Market Poised for Steady Growth on the Back of Rising Healt …
The Europe Insect Screen Market continues to gain momentum, driven by heightened emphasis on public health, energy efficiency, and sustainable building solutions. Valued at US$ 285.4 Mn in 2024, the market is set to grow consistently and reach US$ 480.0 Mn by 2035, expanding at a CAGR of 5.0% during the forecast period.
Increasing focus on maintaining hygienic indoor environments, coupled with advancements in building technologies, is accelerating the adoption of…
Tennis Ball Machines Market to Reach USD 40.3 Million by 2035, Driven by Rising …
According to a new research report published by Transparency Market Research, the global tennis ball machines market was valued at US$ 27.4 Mn in 2024 and is projected to reach US$ 40.3 Mn by 2035, expanding at a CAGR of 3.4% from 2025 to 2035. The market is witnessing steady expansion driven by a surge in tennis participation, rising adoption of advanced training tools, and strong consumer preference for lightweight,…
Global Poultry Farming Equipment Market to Reach USD 6.7 Bn by 2034, Driven by A …
The global poultry industry is entering a new era of modernization as farms worldwide adopt advanced, automated equipment to meet soaring demand for poultry products. According to the latest market assessment, the global poultry farming equipment market was valued at US$ 4.1 Bn in 2023 and is projected to expand steadily at a CAGR of 4.5% from 2024 to 2034, reaching US$ 6.7 Bn by 2034. This growth is fueled…
Europe External Blinds Market Set to Reach USD 22.9 Billion by 2034, Driven by S …
The Europe External Blinds Market is positioned for steady growth over the next decade, with market value expected to rise from US$ 15.2 billion in 2023 to US$ 22.9 billion by 2034, expanding at a CAGR of 3.9% from 2024 to 2034. Increasing adoption of smart home solutions, rising environmental consciousness, and strong government regulations supporting energy efficiency are key factors contributing to this growth.
Introduction: External blinds have emerged as…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
